Literature DB >> 6749749

Heterotopic corneal grafting in mice: a new approach to the study of corneal alloimmunity.

J W Streilein, J McCulley, J Y Niederkorn.   

Abstract

Heterotopic grafting of murine corneas to the thoracic cage of recipient mice affords an opportunity to study the alloimmune rejection process in this well-characterized laboratory species. Immune rejection of cornea allografts can be reliably identified by direct visual, slit-lamp, and histologic observations. Virtually intact syngeneic corneal epithelium and stroma survive at the heterotopic site for at least 21 days. Allogeneic corneal epithelium is destroyed by an intense fibrovascular infiltrative process. If Descemet's membrane is preserved, integrity of the stroma and epithelium of syngeneic corneal grafts is preserved, whereas when this membrane is broken, progressive stromal deterioration sets in. This property of Descemet's membrane is particularly apparent in allogeneic corneal grafts.

Entities:  

Mesh:

Year:  1982        PMID: 6749749

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  12 in total

1.  Evaluation of corneal graft rejection in a mouse model.

Authors:  J Plsková; L Kuffová; V Holán; M Filipec; J V Forrester
Journal:  Br J Ophthalmol       Date:  2002-01       Impact factor: 4.638

2.  Inhibition of corneal allograft reaction by CTLA4-Ig.

Authors:  F Hoffmann; E P Zhang; T Pohl; U Kunzendorf; J Wachtlin; S Bulfone-Paus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-08       Impact factor: 3.117

Review 3.  Regional differences in immune regulation: the immunogenic privilege of corneal allografts.

Authors:  J Y Niederkorn; J S Peeler
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

4.  A murine model of interlamellar corneal transplantation.

Authors:  C H Lau; S M Nicholls; D L Easty
Journal:  Br J Ophthalmol       Date:  1998-03       Impact factor: 4.638

5.  UVB irradiation renders corneal allografts tolerogenic for allospecific delayed hypersensitivity responses.

Authors:  J Y Niederkorn; E Mayhew
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

6.  Immunology of the eye--1983.

Authors:  B J Mondino
Journal:  Surv Immunol Res       Date:  1984

7.  Use of Post-transplant Cyclophosphamide Treatment to Build a Tolerance Platform to Prevent Liquid and Solid Organ Allograft Rejection.

Authors:  Casey O Lightbourn; Dietlinde Wolf; Sabrina N Copsel; Ying Wang; Brent J Pfeiffer; Henry Barreras; Cameron S Bader; Krishna V Komanduri; Victor L Perez; Robert B Levy
Journal:  Front Immunol       Date:  2021-03-02       Impact factor: 7.561

8.  In vivo downregulation of innate and adaptive immune responses in corneal allograft rejection by HC-HA/PTX3 complex purified from amniotic membrane.

Authors:  Hua He; Yaohong Tan; Stephanie Duffort; Victor L Perez; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-19       Impact factor: 4.799

9.  Composition of cellular infiltrates in rejected human corneal allografts.

Authors:  J S Pepose; M S Nestor; K M Gardner; R Y Foos; T H Pettit
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1985       Impact factor: 3.117

10.  Leflunomide therapy following penetrating keratoplasty in the rat.

Authors:  S E Coupland; S Klebe; A C Karow; L Krause; H Kruse; R R Bartlett; F Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-10       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.